Jade Biosciences (JBIO) Assets Average (2021 - 2026)

Jade Biosciences' Assets Average history runs 6 years deep, the most recent figure standing at $334.6 million for Q1 2026.

• Quarterly Assets Average rose 345.16% year-over-year to $334.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $334.6 million (up 345.16% YoY) and the FY2025 annual result came in at $211.3 million, up 111.06% from the prior year.
• Assets Average was $334.6 million for Q1 2026 at Jade Biosciences, up from $276.1 million in the prior quarter.
• Across five years, Assets Average topped out at $334.6 million in Q1 2026 and bottomed at $75.2 million in Q1 2025.
• A 5-year average of $155.1 million and a median of $141.5 million in 2022 frame the typical range for Assets Average.
• Annual changes were most pronounced in 2024 — Assets Average plunged 38.96% — and 2026, when it jumped 345.16%.
• Jade Biosciences' Assets Average stood at $141.5 million in 2022, then dropped by 5.18% to $134.1 million in 2023, then plunged by 38.96% to $81.9 million in 2024, then surged by 237.22% to $276.1 million in 2025, then advanced by 21.18% to $334.6 million in 2026.
• Business Quant data shows JBIO's Assets Average at $334.6 million in Q1 2026, $276.1 million in Q4 2025, and $213.2 million in Q3 2025.